In search of environmental risk factors for obsessive-compulsive disorder: study protocol for the OCDTWIN project.
Discordant twins
Early intervention
Environmental risk factors
Monozygotic twins
Obsessive-compulsive disorder
Prevention
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
16 06 2023
16 06 2023
Historique:
received:
05
05
2023
accepted:
22
05
2023
medline:
19
6
2023
pubmed:
17
6
2023
entrez:
16
6
2023
Statut:
epublish
Résumé
The causes of obsessive-compulsive disorder (OCD) remain unknown. Gene-searching efforts are well underway, but the identification of environmental risk factors is at least as important and should be a priority because some of them may be amenable to prevention or early intervention strategies. Genetically informative studies, particularly those employing the discordant monozygotic (MZ) twin design, are ideally suited to study environmental risk factors. This protocol paper describes the study rationale, aims, and methods of OCDTWIN, an open cohort of MZ twin pairs who are discordant for the diagnosis of OCD. OCDTWIN has two broad aims. In Aim 1, we are recruiting MZ twin pairs from across Sweden, conducting thorough clinical assessments, and building a biobank of biological specimens, including blood, saliva, urine, stool, hair, nails, and multimodal brain imaging. A wealth of early life exposures (e.g., perinatal variables, health-related information, psychosocial stressors) are available through linkage with the nationwide registers and the Swedish Twin Registry. Blood spots stored in the Swedish phenylketonuria (PKU) biobank will be available to extract DNA, proteins, and metabolites, providing an invaluable source of biomaterial taken at birth. In Aim 2, we will perform within-pair comparisons of discordant MZ twins, which will allow us to isolate unique environmental risk factors that are in the causal pathway to OCD, while strictly controlling for genetic and early shared environmental influences. To date (May 2023), 43 pairs of twins (21 discordant for OCD) have been recruited. OCDTWIN hopes to generate unique insights into environmental risk factors that are in the causal pathway to OCD, some of which have the potential of being actionable targets.
Sections du résumé
BACKGROUND
The causes of obsessive-compulsive disorder (OCD) remain unknown. Gene-searching efforts are well underway, but the identification of environmental risk factors is at least as important and should be a priority because some of them may be amenable to prevention or early intervention strategies. Genetically informative studies, particularly those employing the discordant monozygotic (MZ) twin design, are ideally suited to study environmental risk factors. This protocol paper describes the study rationale, aims, and methods of OCDTWIN, an open cohort of MZ twin pairs who are discordant for the diagnosis of OCD.
METHODS
OCDTWIN has two broad aims. In Aim 1, we are recruiting MZ twin pairs from across Sweden, conducting thorough clinical assessments, and building a biobank of biological specimens, including blood, saliva, urine, stool, hair, nails, and multimodal brain imaging. A wealth of early life exposures (e.g., perinatal variables, health-related information, psychosocial stressors) are available through linkage with the nationwide registers and the Swedish Twin Registry. Blood spots stored in the Swedish phenylketonuria (PKU) biobank will be available to extract DNA, proteins, and metabolites, providing an invaluable source of biomaterial taken at birth. In Aim 2, we will perform within-pair comparisons of discordant MZ twins, which will allow us to isolate unique environmental risk factors that are in the causal pathway to OCD, while strictly controlling for genetic and early shared environmental influences. To date (May 2023), 43 pairs of twins (21 discordant for OCD) have been recruited.
DISCUSSION
OCDTWIN hopes to generate unique insights into environmental risk factors that are in the causal pathway to OCD, some of which have the potential of being actionable targets.
Identifiants
pubmed: 37328750
doi: 10.1186/s12888-023-04897-4
pii: 10.1186/s12888-023-04897-4
pmc: PMC10273515
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
442Subventions
Organisme : NIMH NIH HHS
ID : R01 MH110427
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© 2023. The Author(s).
Références
Neurosci Biobehav Rev. 2022 May;136:104602
pubmed: 35271916
Transl Psychiatry. 2020 Oct 8;10(1):342
pubmed: 33033241
Biometrics. 2008 Sep;64(3):772-780
pubmed: 18047524
Compr Psychiatry. 2011 Mar-Apr;52(2):181-7
pubmed: 21295225
Psychol Assess. 2002 Dec;14(4):485-96
pubmed: 12501574
Twin Res Hum Genet. 2006 Dec;9(6):875-82
pubmed: 17254424
Nat Commun. 2018 May 25;9(1):2064
pubmed: 29802345
Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):6830-6835
pubmed: 28607055
Res Dev Disabil. 2013 Jul;34(7):2224-33
pubmed: 23643773
Psychol Med. 2019 Apr;49(6):1015-1024
pubmed: 29950186
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Nature. 2007 Aug 23;448(7156):894-900
pubmed: 17713528
Am J Psychiatry. 2014 Mar;171(3):340-9
pubmed: 24220667
Nat Med. 2018 Dec;24(12):1910-1918
pubmed: 30374196
Nord J Psychiatry. 2014 Nov;68(8):549-59
pubmed: 24568661
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Mol Psychiatry. 2002;7 Suppl 2:S24-5
pubmed: 12142939
Neuropsychopharmacology. 2014 Jun;39(7):1547-57
pubmed: 24407265
JAMA Psychiatry. 2013 Jul;70(7):709-17
pubmed: 23699935
Eur J Epidemiol. 2009;24(11):659-67
pubmed: 19504049
Neurosci Biobehav Rev. 2008;32(3):525-49
pubmed: 18061263
Transl Psychiatry. 2013 Feb 19;3:e228
pubmed: 23423137
Am J Psychiatry. 2016 Sep 9;174(1):60-69
pubmed: 27609241
Laterality. 2013;18(3):340-8
pubmed: 22747439
Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):710-20
pubmed: 19051237
Depress Anxiety. 2016 Mar;33(3):171-8
pubmed: 26629974
Mol Psychiatry. 2018 Jul;23(7):1659-1665
pubmed: 28761079
Science. 2008 Jul 18;321(5887):421-2
pubmed: 18635808
Am J Psychiatry. 2012 Oct;169(10):1100-8
pubmed: 23032388
Soc Psychiatry Psychiatr Epidemiol. 2020 Oct;55(10):1383-1393
pubmed: 31907560
J Affect Disord. 2022 Dec 1;318:204-216
pubmed: 36041582
J Psychiatry Neurosci. 2014 Sep;39(5):304-11
pubmed: 24866415
Nat Neurosci. 2013 Apr;16(4):386-7
pubmed: 23434914
Nat Rev Neurosci. 2012 Oct;13(10):701-12
pubmed: 22968153
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Twin Res Hum Genet. 2019 Dec;22(6):672-680
pubmed: 31747977
Mol Psychiatry. 2018 May;23(5):1181-1188
pubmed: 28761083
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Brain Behav. 2020 Jun;10(6):e01605
pubmed: 32285644
Nat Genet. 2021 Jan;53(1):27-34
pubmed: 33414551
Arch Gen Psychiatry. 2009 Nov;66(11):1189-200
pubmed: 19884607
Am J Psychiatry. 2018 May 1;175(5):453-462
pubmed: 29377733
Nat Commun. 2019 Jul 31;10(1):3417
pubmed: 31366909
Mol Psychiatry. 2013 Jul;18(7):788-98
pubmed: 22889921
Mol Psychiatry. 2015 Mar;20(3):337-44
pubmed: 24821223
Twin Res Hum Genet. 2011 Dec;14(6):495-508
pubmed: 22506305
Percept Mot Skills. 1988 Aug;67(1):3-36
pubmed: 3211683
Br J Psychiatry. 2017 Jan;210(1):67-74
pubmed: 27198485
JAMA Psychiatry. 2013 Jun;70(6):619-29
pubmed: 23740050
Nat Commun. 2018 Sep 24;9(1):3876
pubmed: 30250030
Mol Psychiatry. 2009 Jan;14(1):6-9
pubmed: 19096451
J Child Psychol Psychiatry. 2001 Feb;42(2):241-51
pubmed: 11280420
Arch Gen Psychiatry. 2010 Jul;67(7):701-11
pubmed: 20603451
JAMA Psychiatry. 2018 Jan 1;75(1):47-55
pubmed: 29141084
Nat Rev Neurosci. 2014 Jun;15(6):410-24
pubmed: 24840803
Eur J Epidemiol. 2016 Feb;31(2):125-36
pubmed: 26769609
Neurosci Biobehav Rev. 2016 Jun;65:36-62
pubmed: 27013116
Twin Res Hum Genet. 2014 Jun;17(3):164-76
pubmed: 24735654
BMC Psychiatry. 2020 Oct 14;20(1):507
pubmed: 33054774
Microbiol Res. 2011 Feb 20;166(2):99-110
pubmed: 20223646
Biol Psychiatry. 2023 Jun 1;93(11):1023-1030
pubmed: 36155699
Transl Psychiatry. 2021 Mar 17;11(1):173
pubmed: 33731673
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
J Autism Dev Disord. 2019 Mar;49(3):819-833
pubmed: 30361940
Br J Psychiatry. 2014 Nov;205(5):376-82
pubmed: 25257066
Nat Commun. 2017 Oct 17;8(1):774
pubmed: 29042551
Epidemiology. 2017 Jul;28(4):540-547
pubmed: 28575894
Twin Res Hum Genet. 2013 Feb;16(1):317-29
pubmed: 23137839
Am J Med Genet B Neuropsychiatr Genet. 2020 Jan;183(1):38-50
pubmed: 31424634
Schizophr Bull. 1995;21(3):357-66
pubmed: 7481567
Acta Obstet Gynecol Scand. 2003 Jun;82(6):491-2
pubmed: 12780418
Nat Commun. 2017 Jun 01;8:15493
pubmed: 28569757
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791
Front Psychiatry. 2016 Mar 18;7:35
pubmed: 27047397
J Neurooncol. 2015 Oct;125(1):75-8
pubmed: 26290144
Twin Res Hum Genet. 2018 Feb;21(1):1-11
pubmed: 29307321